Exact Sciences (EXAS) Tops Q4 EPS by 27c, Offers Guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.06), $0.27 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $713.4 million versus the consensus estimate of $694.92 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.03-3.09 billion, versus the consensus of $3.06 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
- Kotak Upgrades Narayana Hrudayalaya Ltd (NARH:IN) to Buy (1)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
